Imricor Medical Systems Inc Cash Flow Conversion Efficiency
Imricor Medical Systems Inc cash flow conversion efficiency. Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.853x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.84 Million ≈ $-6.96 Million USD) by net assets (AU$11.53 Million ≈ $8.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Imricor Medical Systems Inc (2016–2025)
Cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2025. This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Imricor Medical Systems Inc (IMR) stock price for real-time trading data and today's change.
Imricor Medical Systems Inc Cash Flow Conversion Ratio Explained
Imricor Medical Systems Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency. Also see IMR market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cardinal Infrastructure Group Inc. Class A Common Stock
NASDAQ:CDNL
|
0.021x |
|
Putnam Premier Income Trust
NYSE:PPT
|
N/A |
|
CHEERWIN GRP. -0000002
F:1RQ
|
N/A |
|
Beijing InHand Networks Technology Co Ltd
SHG:688080
|
0.071x |
|
Exemplar REITail Ltd
JSE:EXP
|
0.021x |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
0.048x |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
0.036x |
|
Xinjiang Haoyuan Natural Gas Co Ltd
SHE:002700
|
0.026x |
Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2025. Review financial flexibility index of Imricor Medical Systems Inc to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AU$11.53 Million ≈ $8.16 Million |
AU$-19.75 Million ≈ $-13.97 Million |
-1.712x | -181.12% |
| 2024-12-31 | AU$-7.38 Million ≈ $-5.22 Million |
AU$-15.57 Million ≈ $-11.02 Million |
2.111x | +42.40% |
| 2023-12-31 | AU$-8.75 Million ≈ $-6.19 Million |
AU$-12.98 Million ≈ $-9.18 Million |
1.483x | +167.44% |
| 2022-12-31 | AU$7.51 Million ≈ $5.31 Million |
AU$-16.51 Million ≈ $-11.68 Million |
-2.198x | -181.58% |
| 2021-12-31 | AU$22.40 Million ≈ $15.85 Million |
AU$-17.49 Million ≈ $-12.37 Million |
-0.781x | -83.94% |
| 2020-12-31 | AU$28.82 Million ≈ $20.39 Million |
AU$-12.23 Million ≈ $-8.65 Million |
-0.424x | +54.96% |
| 2019-12-31 | AU$7.03 Million ≈ $4.98 Million |
AU$-6.63 Million ≈ $-4.69 Million |
-0.942x | -100.20% |
| 2018-12-31 | AU$13.47 Million ≈ $9.53 Million |
AU$-6.34 Million ≈ $-4.49 Million |
-0.471x | -143.77% |
| 2017-12-31 | AU$-5.25 Million ≈ $-3.72 Million |
AU$-5.65 Million ≈ $-4.00 Million |
1.075x | +6.98% |
| 2016-12-31 | AU$-4.03 Million ≈ $-2.85 Million |
AU$-4.05 Million ≈ $-2.87 Million |
1.005x | -- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more